NewAmsterdam Pharma Company NV
NAMS35.110USD
+1.210+3.57%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
3.97BMarket Cap
LossP/E TTM
NewAmsterdam Pharma Company NV Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
45.56M
223.37%
EPS(YoY)
-2.56
-18.90%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its total revenue reached 45.56M, with a year-on-year change of 223.37%.
What is the Earnings Per Share (EPS) of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its Earnings Per Share (EPS) was -2.560, with a year-on-year change of -18.90%.
What is the net income of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its net income was -241.60M, with a year-on-year change of -36.54%.
What is the net margin of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its net profit margin was -530.25%, with a year-on-year change of 57.77%.
What is the gross margin of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its Return on Equity (ROE) was -46.20%, with a year-on-year change of 6.20%.
What is the Return on Assets (ROA) of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its Return on Assets (ROA) was -39.88%, with a year-on-year change of 6.97%.
What is the operating profit of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its operating profit was -176.29M, with a year-on-year change of -0.68%.
What are the current assets of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its current assets were 863.41M, with a year-on-year change of 148.97%.
What are the total assets of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its total assets of NewAmsterdam Pharma Company NV were 864.62M, with a year-on-year change of 149.10%.
What are the total liabilities of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its total liabilities of NewAmsterdam Pharma Company NV were 107.12M, with a year-on-year change of 82.47%.
What is the total equity of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its total equity of NewAmsterdam Pharma Company NV was 757.50M, with a year-on-year change of 162.66%.
What is the net operating income of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its net operating income of NewAmsterdam Pharma Company NV was -241.60M, with a year-on-year change of -36.54%.
What is the net investment of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its net investment of NewAmsterdam Pharma Company NV was -62.85M, with a year-on-year change of -261766.67%.
What is the net financing of NewAmsterdam Pharma Company NV?
According to NewAmsterdam Pharma Company NV's FY2024 earnings report, its net financing of NewAmsterdam Pharma Company NV was 659.51M, with a year-on-year change of 7300.21%.
